Results 241 to 250 of about 66,017 (306)

Mapping Research Trends on Intestinal Permeability in Irritable Bowel Syndrome with a Focus on Nutrition: A Bibliometric Analysis. [PDF]

Nutrients
Mallardi D, Maqoud F, Guido D, Aloisio M, Linsalata M, Russo F.   +5 more
europepmc   +1 more source

The Association of Avoidant/Restrictive Food Intake Disorder (ARFID) and Neurogastroenterology Disorders (Including Disorders of Gut–Brain Interaction [DGBI]): A Scoping Review

Neurogastroenterology &Motility, EarlyView.
This scoping review found that avoidant/restrictive food intake disorder (ARFID) symptoms are highly prevalent in neurogastroenterology disorders such as disorders of gut–brain interaction (DGBI), and vice versa. Patients with an ARFID‐neurogastroenterology disorder overlap were found to have higher anxiety and depression levels, and a lower quality of
Hiba Mikhael‐Moussa, Valérie Bertrand, Emeline Lejeune, Claire Dupont, Alexandra Aupetit, Najate Achamrah, Chloé Melchior   +6 more
wiley   +1 more source

The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review. [PDF]

Microorganisms
Kasti A, Katsas K, Nikolaki MD, Triantafyllou K.   +3 more
europepmc   +1 more source

IL-10 and TGF-B genotypes in irritable bowel syndrome: Evidence to support an inflammatory component

, 2000
Joyce Chan, Wendy M. Gonsalkorale, Christopher Perrey, Vera Previca, Ali H. Hajeer, Peter J. Whorwell, Ian V. Hutchinson   +6 more
openalex   +1 more source

A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction

Neurogastroenterology &Motility, EarlyView.
The pathophysiology of functional dyspepsia and irritable bowel syndrome includes altered motility, secretion, sensitivity to sensory signals, impaired epithelial barrier function, inflammation, and gut dysbiosis. The phytomedicine, STW 5‐II, represents a multi‐targeted approach, addressing these pathophysiologies.
Anita Annaházi, Rudolf Bauer, Thomas Efferth, Mohamed T. Khayyal, Michael Schemann, Gudrun Ulrich‐Merzenich, Christine Feinle‐Bisset   +6 more
wiley   +1 more source

The Gut-Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention-A Narrative Review. [PDF]

Health Sci Rep
Soufan F, Ghosson A, Jaber R, Ghandour A, Uwishema O.   +4 more
europepmc   +1 more source

Validation of the PROMIS Global Physical and Mental Health Scale for Gastrointestinal Disorders: A Large‐Scale Cross‐Sectional Survey

Neurogastroenterology &Motility, EarlyView.
The 4‐item revised version of the Hays model from the PROMIS Global Health Scale exhibits stronger psychometric properties than the original model. This ultra‐brief assessment tool is a reliable measure for evaluating quality of life in both gastrointestinal and non‐gastrointestinal cohorts.
Pragalathan Apputhurai, Olafur S. Palsson, Shrikant I. Bangdiwala, Ami D. Sperber, Antonina Mikocka‐Walus, Simon R. Knowles   +5 more
wiley   +1 more source

Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review. [PDF]

J Clin Med
Lopes CM, de Jesus Monteiro CS, Duarte AP, Dos Santos JL.   +3 more
europepmc   +1 more source

Efficacy of Mediterranean Diet vs. Low‐FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial

Neurogastroenterology &Motility, EarlyView.
In the first head‐to‐head comparison of the Mediterranean diet (MD) with the low FODMAP diet, the MD improved abdominal symptoms in a majority of patients with irritable bowel syndrome (IBS). However, the magnitude of improvement with the Low FODMAP diet was greater compared to the MD.
Prashant Singh, Gregory Dean, Sofia Iram, Westley Peng, Samuel W. Chey, Samara Rifkin, Christine Lothen‐Kline, Jane Muir, Allen A. Lee, Shanti Eswaran, William D. Chey   +10 more
wiley   +1 more source